1. Home
  2. WDS vs KVUE Comparison

WDS vs KVUE Comparison

Compare WDS & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Woodside Energy Group Limited

WDS

Woodside Energy Group Limited

HOLD

Current Price

$21.89

Market Cap

31.8B

Sector

Energy

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.30

Market Cap

36.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDS
KVUE
Founded
1954
2022
Country
Australia
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Specialty Chemicals
Sector
Energy
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.8B
36.6B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
WDS
KVUE
Price
$21.89
$18.30
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$19.64
AVG Volume (30 Days)
928.4K
48.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.93%
4.56%
EPS Growth
N/A
40.74
EPS
N/A
0.76
Revenue
N/A
$15,124,000,000.00
Revenue This Year
N/A
$4.80
Revenue Next Year
$14.21
$2.52
P/E Ratio
$11.81
$24.01
Revenue Growth
N/A
N/A
52 Week Low
$11.26
$14.02
52 Week High
$21.96
$25.17

Technical Indicators

Market Signals
Indicator
WDS
KVUE
Relative Strength Index (RSI) 80.77 49.39
Support Level $15.29 $16.73
Resistance Level N/A $18.97
Average True Range (ATR) 0.45 0.37
MACD 0.23 -0.09
Stochastic Oscillator 99.38 25.21

Price Performance

Historical Comparison
WDS
KVUE

About WDS Woodside Energy Group Limited

Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: